Citadel’s portfolio isn’t really a stock portfolio—it’s a risk machine. We unpack Ken Griffin’s latest 13F, its thousands of positions, huge index exposure, mega-cap holdings, options maze and the lessons retail investors can actually steal.

Read entire article

Brad Jacobs is transforming QXO into an $18 billion building-products platform with ambitions to reach $50 billion in annual revenue. But after Beacon, Kodiak and TopBuild, common shareholders must weigh elite M&A leadership against substantial debt, preferred dividends, integration risk and an enormous potential dilution overhang.

Read entire article

Michael Burry has moved beyond Scion Asset Management—but certainly not beyond contrarian investing. The Big Short investor is challenging the AI and semiconductor boom while simultaneously buying beaten-down companies including MercadoLibre, Birkenstock, Sprouts, QXO and Build-A-Bear. We examine his long-dated put strategy, current value picks, legendary research process—and the timing risk behind the Cassandra mystique.

Read entire article

Berkshire Hathaway just added roughly $212 million of Lennar near $77 after a difficult Q3 sent investors running from the homebuilder. With LEN trading around 0.85x book value, record 116-day construction cycle times and 9.5% short float—but falling orders, compressed margins and punishing mortgage rates—is Berkshire buying into the housing cycle too early, or exactly when a patient value investor should?

Read entire article

Steve Mandel’s Lone Pine Capital surged 43% in the first half of 2026. We dig into the $25B+ Tiger Cub’s Q2 portfolio, Nebius and Home Depot bets, long-term record, management obsession—and why “duration” may be its most important edge.

Read entire article

Group 1 Automotive has fallen roughly 41% from its peak, earnings are weakening and auto affordability is under pressure. Yet Conifer Management just bought another $40.6 million of GPI near $290. With the stock around 6× forward earnings, a powerful service business and a $1.7 billion Hennessy expansion ahead, is this falling knife becoming a bargain?

Read entire article

Larry Robbins has built Glenview Capital around fundamental research, concentrated conviction and an unusual willingness to act like an owner. We examine its ~$5.5B Q2 2026 portfolio, CVS activism, healthcare bets, extraordinary early track record—and why hockey may explain more about Robbins than you'd expect. 🏒

Read entire article

Ron Baron built an investing career around a deceptively difficult idea: find exceptional businesses, back exceptional leaders and wait. We examine Baron Partners Fund, its huge SpaceX and Tesla exposure, long-term compounding record—and the concentration risk that comes with conviction.

Read entire article

Steve Cohen didn't simply build another hedge fund.

He engineered an institutional investment machine.

Discover how Point72's Academy, 200+ autonomous investment pods, Cubist quantitative platform, and disciplined organizational design transformed it into one of Wall Street's most formidable alpha factories.

Read entire article

Thryv was once known for Yellow Pages directories. Today, roughly 76% of its revenue comes from SaaS, management is expanding its AI platform, and legendary investor John Paulson continues buying shares. We examine whether Wall Street is still valuing yesterday's business while tomorrow's company quietly takes shape.

Read entire article